Takagi Junko, Otake Kazuo, Takahashi Masahiko, Nakao Naoki, Hirooka Yoshifumi, Sahashi Ko, Nogimori Tsuyoshi
Department of Laboratory Medicine, Aichi Medical University School of Medicine, 21 Karimata, Nagakute, Aichi 480-1195.
Intern Med. 2003 Nov;42(11):1117-21. doi: 10.2169/internalmedicine.42.1117.
A 49-year-old man with syringomyelia and a Type I Arnold-Chiari malformation (Chiari-I) was diagnosed with growth hormone insensitivity syndrome (GHIS). He was short in stature, had high circulating levels of GH, and low circulating levels of insulin-like growth factor-I (IGF-I) and IGF binding protein-3 (IGFBP-3). His GH responses to the administration of growth hormone-releasing hormone (GHRH) and L-DOPA were normal, but his levels of IGF-I and IGFBP-3 did not increase after the administration of exogenous GH. Direct genomic DNA sequencing revealed neither a mutation nor deletion in this patient's GH receptor (GHR) gene, though one polymorphism was detected, indicating that his GHR gene was normal. This is the first reported case of an association of GHIS with syringomyelia and Chiari-I malformation.
一名患有脊髓空洞症和Ⅰ型阿诺德-基亚里畸形(Chiari-I)的49岁男性被诊断为生长激素不敏感综合征(GHIS)。他身材矮小,循环生长激素(GH)水平高,而胰岛素样生长因子-I(IGF-I)和IGF结合蛋白-3(IGFBP-3)的循环水平低。他对生长激素释放激素(GHRH)和左旋多巴给药的GH反应正常,但给予外源性GH后,他的IGF-I和IGFBP-3水平并未升高。直接基因组DNA测序显示该患者的生长激素受体(GHR)基因既无突变也无缺失,尽管检测到一个多态性,表明他的GHR基因正常。这是首次报道的GHIS与脊髓空洞症和Chiari-I畸形相关的病例。